T. Hirose, E. Okezaki; H. Kato; Y. Ito; M. Inoue; S. Mitsuhashi, In vitro and in vivo activity of NY-198, a new difluorinated quinolone., in Antimicrob Agents Chemother, vol. 31, n. 6, Jun 1987, pp. 854-9, PMID 3476021.
D. Hoban, P. DeGagne; E. Witwicki, In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum., in Diagn Microbiol Infect Dis, vol. 12, 3 Suppl, pp. 83S-86S, PMID 2507222.
CA. DiVincenzo, KL. Shatzer; FR. Venezio, In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis., in Diagn Microbiol Infect Dis, vol. 12, 3 Suppl, pp. 13S-16S, PMID 2507220.
NX. Chin, A. Novelli; HC. Neu, In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones., in Antimicrob Agents Chemother, vol. 32, n. 5, maggio 1988, pp. 656-62, PMID 3164987.
R. Wise, JM. Andrews; JP. Ashby; RS. Matthews, In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents., in Antimicrob Agents Chemother, vol. 32, n. 5, maggio 1988, pp. 617-22, PMID 3134843.
GM. Rossolini, S. Valentini; G. Satta, Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa., in Diagn Microbiol Infect Dis, vol. 12, 3 Suppl, pp. 57S-64S, PMID 2507221.
JW. Stone, JM. Andrews; JP. Ashby; D. Griggs; R. Wise, Pharmacokinetics and tissue penetration of orally administered lomefloxacin., in Antimicrob Agents Chemother, vol. 32, n. 10, Oct 1988, pp. 1508-10, PMID 3190181.
M. Neuman, Clinical pharmacokinetics of the newer antibacterial 4-quinolones., in Clin Pharmacokinet, vol. 14, n. 2, Feb 1988, pp. 96-121, PMID 3282749.
I. Gros, C. Carbon, Pharmacokinetics of lomefloxacin in healthy volunteers: comparison of 400 milligrams once daily and 200 milligrams twice daily given orally for 5 days., in Antimicrob Agents Chemother, vol. 34, n. 1, Jan 1990, pp. 150-2, PMID 2327750.
E. Okezaki, T. Terasaki; M. Nakamura; O. Nagata; H. Kato; A. Tsuji, Serum protein binding of lomefloxacin, a new antimicrobial agent, and its related quinolones., in J Pharm Sci, vol. 78, n. 6, Jun 1989, pp. 504-7, PMID 2760827.
E. Pisani, R. Bartoletti; A. Trinchieri; M. Rizzo, Lomefloxacin versus ciprofloxacin in the treatment of complicated urinary tract infections: a multicenter study., in J Chemother, vol. 8, n. 3, Jun 1996, pp. 210-3, PMID 8808718.
IW. Klimberg, CE. Cox; CL. Fowler; W. King; SS. Kim; S. Callery-D'Amico, A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection., in Urology, vol. 51, n. 4, Apr 1998, pp. 610-5, PMID 9586615.
J. Guibert, H. Herman; MH. Capron, [Treatment of uncomplicated recurrent cystitis in women: lomefloxacin versus norfloxacin]., in Contracept Fertil Sex, vol. 25, n. 1, Jan 1997, pp. 79-84, PMID 9064058.
VT. Andriole, Use of quinolones in treatment of prostatitis and lower urinary tract infections., in Eur J Clin Microbiol Infect Dis, vol. 10, n. 4, Apr 1991, pp. 342-50, PMID 1864295.
KG. Naber, Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis., in Int J Antimicrob Agents, vol. 20, n. 1, Jul 2002, pp. 18-27, PMID 12127707.
FJ. Costa, Lomefloxacin prophylaxis in visual laser ablation of the prostate., in Urology, vol. 44, n. 6, Dec 1994, pp. 933-6, PMID 7527170.
AS. Melani, M. Pirrelli; F. Sarlo; V. Cantoni, Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines., in J Chemother, vol. 13, n. 6, Dec 2001, pp. 628-34, PMID 11806624.
GB. Fedoseev, AV. Emel'ianov; KA. Rudinskiĭ; SE. Shevelev; AV. Bykova, [Efficacy of lomefloxacin in treatment of patients with chronic bronchitis]., in Antibiot Khimioter, vol. 43, n. 10, pp. 24-6, PMID 9825106.
C. Grassi, C. Albera; E. Pozzi, Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study., in Am J Med, vol. 92, 4A, Apr 1992, pp. 103S-107S, PMID 1316058.
IuB. Belousov, OV. Efremenkova; AV. Sokolov; IF. Tishenkova, [The importance of fluoroquinolones in treating pneumonia in the elderly]., in Antibiot Khimioter, vol. 44, n. 12, 1999, pp. 23-6, PMID 10687030.
S. Kohno, K. Yamaguchi; Y. Dohtsu; H. Koga; T. Hayashi; M. Hirota; A. Saito; K. Hara, Efficacy of NY-198 against experimental Legionnaires disease., in Antimicrob Agents Chemother, vol. 32, n. 9, Sep 1988, pp. 1427-9, PMID 3196003.
